Dr. Peng Zhang's research mainly focuses on cardiac fibroblasts and the regulation of their function under a variety of pathological conditions such as high blood pressure and after heart attacks. While fibroblasts are important cellular targets for treatment of cardiac remodeling, efforts to develop the treatments that specifically target fibroblasts are still at an early stage. Our goal is to devise new therapeutic strategies that ultimately should benefit patients with cardiovascular disease.
Dr. Zhang was promoted to Instructor in Medicine in 2008 and to Assistant Professor of Medicine in 2010 after his postdoctoral training in the Cardiovascular Research Center (CVRC) of the Cardiology Division of Rhode Island Hospital and the Alpert Medical School of Brown University. His research interests concentrate on cardiac remodeling, with a particular focus on cardiac fibroblasts and their role and regulation in the normal and diseased heart. As a principle investigator, his work has been supported by Medical Research Grant from Rhode Island Foundation (2010-2011) and a Pilot Project Award (2011-2013) from NIH COBRE for Perinatal Biology. Recently, Dr. Zhang was awarded by the American Heart Association a National Scientist Development Grant (2013-2016), which aims to support highly promising beginning scientists in their progress toward independence by encouraging and adequately funding research projects that can bridge the gap between completion of research training and readiness for successful competition as an independent investigator.
PENG ZHANG, M.D.
Are you Peng Zhang? Click here to edit your research profile.